ALS, often referred to as Lou Gehrig's disease, is a rare disorder that affects a person's nerves and muscles, leading to paralysis and death within a few years.
Most people with ALS are between 40 and 70 years old -- in the prime of their lives.
While there's no cure, researchers are learning more and more about this deadly disease.
In this segment, Dr. Roizen welcomes Piera Pasinelli and Davide Trotti, co-directors of the Weinberg Unit for ALS Research. They share the latest on how the disease develops and how doctors might be able to fight it.
Treating Lou Gehrig's Disease
Featuring:
Davide Trotti is a Professor of Neuroscience, Co-Director of the Weinberg Unit for ALS Research. He performed his doctoral work at the Universita Degli Studi di Milano and postdoctoral work at Harvard University’s Brigham and Women’s Hospital. His research focuses on the causes of neuronal death in the brain during neuro-degenerative diseases like ALS.
Piera Pasinelli, PhD & Davide Trotti, PhD
Piera Pasinelli is an Associate Professor of Neuroscience, Co-Director of the Weinberg Unit for ALS Research, Co-Director of the Graduate Program in Neuroscience at Thomas Jefferson University and Scientific Director of the Robert Packard Center for ALS Research at Johns Hopkins University. She studied neuro-biochemistry at the University of Utrecht in The Netherlands where she received her PhD, and did her postdoctoral fellowship at Harvard University’s Massachusetts General Hospital. Her research focuses on the molecular mechanisms underlying motor neuron dysfunction and death in ALS.Davide Trotti is a Professor of Neuroscience, Co-Director of the Weinberg Unit for ALS Research. He performed his doctoral work at the Universita Degli Studi di Milano and postdoctoral work at Harvard University’s Brigham and Women’s Hospital. His research focuses on the causes of neuronal death in the brain during neuro-degenerative diseases like ALS.
Transcription:
Tagged under